Natco Tests Compassionate Use Window In India For Merck’s COVID Pill
Merck steps in to seal voluntary licensing deals with five Indian firms
Natco seeks emergency approval in India for investigational therapy molnupiravir, currently being developed by Merck & Co for the treatment of non-hospitalized COVID-19 patients. The firm has linked its request to compassionate use amid a ferocious surge in COVID-19 cases in India, posing a potentially delicate choice for the regulator.
